Posted: October 28, 2008

Nanocenter offers promising non-invasive cancer treatment

(Nanowerk News) A team of scientists at Arkansas Nanotechnology Center at UALR (the University of Arkansas at Little Rock) has developed what promises to be a non-invasive method of eradicating cancer cells while reducing the life-threatening side effects of chemotherapy and radiation.
See our recent Nanowerk Spotlight for more details: Nanotechnology produces highly effective radio frequency absorbers for cancer therapy.
The new technique, described in the current issue of the journal Nanotechnology, was developed by a team led by Dr. Alexandru Biris, assistant professor of applied science and chief scientist at the Nanotechnology Center. Working in collaboration with the University of Arkansas for Medical Sciences, the team successfully killed more than 98 percent of the cervical cancer cells used in the study.
The technique introduces nano-sized cobalt particles encased in graphitic carbon layers inside the cells and thermally activates them by using radio frequency radiation. By applying low radio frequency radiation – used in some electronic or electromagnetic devices – the magnetic portion in the nanoparticles heats up the cancerous cells, destroying them.
The procedure promises a non-invasive method of eradicating cancer cells while reducing the life-threatening side effects of chemotherapy and radiation.
The technique is described in their new research paper, Cobalt Nanoparticles Coated with Graphitic Shells as Localized Radio Frequency Absorbers for Cancer Therapy.
"We have demonstrated that using a combination of a low frequency, low power radio frequency radiation – which has a high penetration ability in human tissue – with graphitic-magnetic composite nanoparticles could prove an excellent means of raising the temperature at the cellular level above the threshold required for DNA fragmentation or protein denaturation,” Biris said. “The result is death of the cells. This technique is less invasive and possesses higher efficiency for targeting localized cells. It also has the potential to reduce the side effects associated with traditional cancer therapies.”
With approved research protocols, UAMS scientists are expanding on previous work involving use of nanostructural materials for killing tumors with lasers. Using this method, the nanomaterials are introduced through the bloodstream to be activated with radio frequency energy once they are in the tumors.
“We believe this method is extremely promising for killing cancer cells,” said Dr. Vladmir Zharov, professor and director of the Phillips Classic Laser Laboratories in the UAMS Winthrop P. Rockefeller Cancer Institute. “We are working now to move this technology toward clinical trials with the ultimate goal of achieving a safe, effective procedure that leaves a patient cancer free.”
Biris, a native of Romania who earned a Ph.D. in applied science at UALR in 2004, said the delivery of the encased nanoparticle to tumors will also be explored by binding them to cancer-specific antibodies.
By using antibodies or other nanoparticle bioconjugations – the coupling of two substances – the nanoparticles are expected to find the cancer cells even in advanced cases, including places that before now have been considered inoperable. The nanoparticles can also find undiagnosed micrometastasis, or the spread of cancer cells from the primary site with the secondary tumors too small to be detected clinically.
“This research has extended the understanding of the mechanisms that are responsible for effective nanoparticle targeting and eventually the death of cancer cells,” Zharov said.
The team’s work is helping to explain the mechanism that is responsible for the death of the cells by figuring out the localized thermal damages such as protein denaturation and DNA fragmentation associated with the process. The finding can be applied to bacteria, viruses, or other biological systems.
Source: University of Arkansas
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: